ARWR
Arrowhead Pharmaceuticals Inc.
Latest News for ARWR
Bank of America Securities analyst Jason Gerberry reiterated a Buy rating on Arrowhead Pharmaceuticals yesterday and set a price target of $81.00. ......
Jefferies analyst maintained a Buy rating on Arrowhead Pharmaceuticals today and set a price target of $67.00. In addition to Jefferies, Arrowhead ......
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Arrowhead Pharmaceuticals (ARWR – Research Report)......
Arrowhead Pharmaceuticals, Inc. ( ($ARWR) ) has released its Q4 earnings. Here is a breakdown of the information Arrowhead Pharmaceuticals, Inc. pr......
In a report released today, from B. Riley Securities reiterated a Buy rating on Arrowhead Pharmaceuticals, with a price target of $61.00. In additi......
An announcement from Arrowhead Pharmaceuticals ( ($ARWR) ) is now available. On November 18, 2025, Arrowhead Pharmaceuticals announced that the FDA......
Several pharmaceutical companies awaiting a decision from U.S. authorities on their drug applications are set to get them this month. These decisio......
News data is sourced from MarketXLS API and updated regularly.
Showing 7 of 7 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ARWR | $70.09 | -1.0% | 1.55M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Arrowhead Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW